未登录 分享 收藏
Intratumoral preservation of the stem-like malignant cell proportion in glioblastoma, prognostic impact, and its radiomethylomic signatures 胶质母细胞瘤中类干细胞恶性细胞比例的瘤内保存、预后影响及其放射甲基组学特征 Matsumoto, Yuji; Singh, Omkar; Garcia, Jose; Abdullaev, Zied; Freeburg, Nelson F.; Yu, Fanyang; Akbari, Hamed; Baik, Kyunglok; Guo, Jun; Shih, Natalie N. C.; Toorens, Erik; Ganguly, Tapan; Ballinger, Dominique; O'Rourke, Donald M.; Mohan, Suyash; Morrissette, Jennifer J. D.; Silverbush, Dana; Aldape, Kenneth; Davatzikos, Christos; Nasrallah, MacLean P. 分享 收藏
分享 收藏
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors EMB-02的首次人体I期研究，EMB-02是一种靶向PD-1和LAG-3的双特异性抗体，用于治疗晚期实体瘤患者 Day, Daphne; Ganju, Vinod; Chung, Ki; Si, Lu; Mao, Lili; Aghmesheh, Morteza; Hoyer, Robert; Brewin, Kim; Zeng, Shuqi; Zhang, Mingfei; Lu, Qiaoyang; Jiang, Chengjun; Ren, Fang; Zhu, Yonghong; Guo, Jun 分享 收藏
Dynamic Change of PD-L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti-PD-1 Therapy 循环血浆外泌体上PD-L2的动态变化作为接受抗PD-1治疗黑色素瘤患者治疗反应的预测指标 Sun, Linzi; Wei, Xiaoting; Zhao, Qian; Mao, Lili; Bai, Xue; Li, Caili; Gu, Junjie; Kong, Yan; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Lian, Bin; Wang, Xuan; Li, Siming; Yan, Xieqiao; Tang, Bixia; Zhou, Li; Li, Juan; Guo, Jun; Si, Lu; Dai, Jie 分享 收藏
分享 收藏
SUBTYPING GLIOBLASTOMA FROM JOINT CLUSTERING OF IMAGING AND GENOMIC DATA Guo, Jun; Fathi-Kazerooni, Anahita; Toorens, Erik; Akbari, Hamed; Yu, Fanyang; Matsumoto, Yuji; Sako, Chiharu; Mamourian, Elizabeth; Shinohara, Russell; Koumenis, Constantinos; Verginadis, Ioannis; Bagley, Stephen; Morrissette, Jennifer; Binder, Zev; Brem, Steven; Mohan, Suyash; Lustig, Robert; O'Rourke, Donald; Ganguly, Tapan; Bakas, Spyridon; Aboian, Mariam; Nasrallah, Maclean; Davatzikos, Christos 分享 收藏
Mucin 18-targeted humanized monoclonal antibody immune positron emission tomography imaging and patient-derived tumor xenograft visualization 粘蛋白18靶向人源化单克隆抗体免疫正电子发射断层显像和患者来源的肿瘤异种移植可视化 Zhang, Qian; Du, Haizhen; Ma, Xiuli; Liu, Song; Kong, Xiangxing; Hu, Muye; Shi, Jing; Tang, Yanfang; Liu, Shuhui; Meng, Xun; Guo, Qian; Kong, Yan; Guo, Jun; Lian, Bin; Yang, Zhi; Zhu, Hua 分享 收藏
Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies Penkov, Konstantin; Bondarenko, Igor; Saenko, Daria Viktorovna; Kulyaba, Yaroslav; Guo, Jun; Gong, Yi; Yamamoto, Noboru; Hotko, Yevhen Stepanovych; Boyko, Vasyl; Fadeeva, Natalya Vladimirovna; Ursol, Grygorii Mykolaiovych; Ahn, Hee Kyung; Kislov, Nikolay Viktorovich; Shen, Chia-, I; Davis, Craig; Kowalski, Karey; Michelon, Elisabete; Pavlov, Dmitri; Hirohashi, Tomoko; Cho, Byoung Chul 分享 收藏
Mechanisms of recurrence following mRNA-4157 (V940) plus pembrolizumab or pembrolizumab alone in resected melanoma from the mRNA-4157-P201 (KEYNOTE-942) trial mRNA-4157（V940）联合pembrolizumab或pembrolizumab单药治疗在切除的黑素瘤中复发的机制：来自mRNA-4157-P201（KEYNOTE-942）试验 Sullivan, R. J.; Lu, M.; Koppolu, S.; Weber, J. S.; Carlino, M. S.; Khattak, M. A.; Ansstas, G.; Taylor, M. H.; Mckean, M.; Long, G. V.; Faries, M. B.; Luke, J. J.; Sehgal, V.; Rao, A.; Mao, H.; Guo, J.; Brown, M.; Meehan, R.; Feldman, I.; Srinivasan, L. 分享 收藏
Phase III study of talazoparib (TALA) plus enzalutamide (ENZA) vs placebo (PBO) plus ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): TALAPRO-2 (TP-2) China cohort Talazoparib (TALA) 联合 Enzalutamide (ENZA) 与 Placebo (PBO) 联合 ENZA 作为转移性去势抵抗性前列腺癌 (mCRPC) 患者的一线 (1L) 治疗的 III 期研究：TALAPRO-2 (TP-2) 中国队列 Zeng, H.; Ye, D.; Guo, H.; Yang, Y.; Xue, B.; Zhang, X.; Xiao, W.; Jiang, J.; Sun, T.; Chen, W.; Wang, Y.; Wan, B.; He, D.; Zhang, Q.; Luo, H.; Wang, X.; Guo, J.; Ye, H.; Zhao, H.; Zhang, Y. 分享 收藏
分享 收藏
Chinese quality control indices for standardized diagnosis and treatment of renal cancer (2022 edition) Yao, Lin; Du, Yicong; Dong, Wen; Gao, Xianshu; Guo, Jun; Qiu, Jianxing; Wei, Qiang; Wu, Shikai; Ye, Dingwei; Yu, Wei; Zeng, Hao; Zhang, Qian; Zhang, Yong; Zhang, Zhiling; Zhou, Fangjian; Yang, Wenjing; Wang, Hui; Zhang, Xu; He, Zhisong 分享 收藏
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study Dabrafenib联合曲美替尼与anti-PD-1单药治疗BRAF V600-mutant III期黑色素瘤确定性手术后的辅助治疗: 一项多中心，回顾性队列研究 Bai, Xue; Shaheen, Ahmed; Grieco, Charlotte; d'Arienzo, Paolo D.; Mina, Florentia; Czapla, Juliane A.; Lawless, Aleigha R.; Bongiovanni, Eleonora; Santaniello, Umberto; Zappi, Helena; Dulak, Dominika; Williamson, Andrew; Lee, Rebecca; Gupta, Avinash; Li, Caili; Si, Lu; Ubaldi, Martina; Yamazaki, Naoya; Ogata, Dai; Johnson, Rebecca; Park, Benjamin C.; Jung, Seungyeon; Madonna, Gabriele; Hochherz, Juliane; Umeda, Yoshiyasu; Nakamura, Yasuhiro; Gebhardt, Christoffer; Festino, Lucia; Capone, Mariaelena; Ascierto, Paolo Antonio; Johnson, Douglas B.; Lo, Serigne N.; Long, Georgina L.; Menzies, Alexander M.; Namikawa, Kenjiro; Mandala, Mario; Guo, Jun; Lorigan, Paul; Najjar, Yana G.; Haydon, Andrew; Quaglino, Pietro; Boland, Genevieve M.; Sullivan, Ryan J.; Furness, Andrew J. S.; Plummer, Ruth; Flaherty, Keith T. 分享 收藏
分享 收藏
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA) Wei, Alexander Z.; Chen, Lanyi N.; Orloff, Marlana; Ariyan, Charlotte E.; Asgari, Maryam; Barker, Christopher A.; Buchbinder, Elizabeth; Chandra, Sunandana; Couts, Kasey; Frumovitz, Michael M.; Futreal, Andrew; Gershenwald, Jeffrey E.; Hanna, Ehab Y.; Izar, Benjamin; Leblanc, Amy K.; Leitao, Mario M.; Lipson, Evan J.; Liu, David; Mccarter, Martin; Mcquade, Jennifer L.; Najjar, Yana; Rapisuwon, Suthee; Selig, Sara; Shoushtari, Alexander N.; Yeh, Iwei; Schwartz, Gary K.; Guo, Jun; Patel, Sapna P.; Carvajal, Richard D. 分享 收藏
Second-line pembrolizumab (pembro) in Chinese patients (pts) with advanced melanoma: Long-term follow-up of the phase I KEYNOTE-151 study Si, L.; Zhang, X.; Shu, Y.; Pan, H.; Wu, D.; Liu, J.; Mao, L.; Wang, X.; Wen, X.; Gu, Y.; Zhu, L.; Lan, S.; Cai, X.; Diede, S.; Chen, S. S.; Hu, H.; Guo, J. 分享 收藏
RENOTORCH: Toripalimab combined with axitinib versus sunitinib in first-line treatment of advanced renal-cell carcinoma (RCC) - A randomized, open-label, phase III study Sheng, X.; Ye, M.; Zou, Q.; Chen, P.; He, Z.; Wu, B.; He, D.; He, C.; Xue, X.; Ji, Z.; Chen, H.; Zhang, S.; Liu, Y.; Zhai, W.; Zhang, X.; Fu, C.; Xu, D.; Qiu, M.; Huang, Y.; Guo, J. 分享 收藏
A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting Melanoma Shi, Jing; Jiao, Tao; Guo, Qian; Weng, Weining; Ma, Linjie; Zhang, Qing; Wang, Lijun; Zhang, Jianjian; Chen, Caiwei; Huang, Yaling; Wang, Mingqiao; Pan, Rong; Tang, Yanfang; Hu, Wenhao; Meng, Tao; Liu, Shu-Hui; Guo, Jun; Kong, Yan; Meng, Xun 分享 收藏
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanoma Du, Yu; Dai, Jie; Mao, Lili; Wei, Xiaoting; Bai, Xue; Chen, Ling; Lin, Jing; Chi, Zhihong; Cui, Chuanliang; Sheng, Xinan; Lian, Bin; Tang, Bixia; Wang, Xuan; Yan, Xieqiao; Li, Siming; Zhou, Li; Guo, Jun; Chen, Yu; Si, Lu 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
.png){kind=icon}
分享.png){kind=icon}
收藏